TerminatedNCT01024322
Collagen Crosslinking With Ultraviolet-A in Asymmetric Corneas
Studying Pellucid marginal degeneration
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Cxlusa
- Principal Investigator
- William Trattler, MD, MDThe Center for Excellence in Eye Care
- Intervention
- Ciprofloxicine or Vigamox or other.(drug)
- Enrollment
- 1189 target
- Eligibility
- 8 years · All sexes
- Timeline
- 2009 – 2017
Study locations (3)
- The Center for Excellence in Eye Care, Miami, Florida, United States
- TLC Laser Eye Center, Rockville, Maryland, United States
- TLC Laser Eye Center, Fairfax, Virginia, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT01024322 on ClinicalTrials.gov